Stock data

諾貝兒 (6844)

諾貝兒 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$309.21M, up 4.1% from a year earlier. EPS over the last four quarters totals NT$3.29.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 諾貝兒 in Insightr